ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting

ClinicalTrials.gov ID: NCT01989156

Public ClinicalTrials.gov record NCT01989156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Controlled, Open-label, 3-arm Parallel Group, Multi-center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Apparently Healthy Smokers Switching to the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol) or Observing Smoking Abstinence, Compared to Continuing to Use Menthol Conventional Cigarettes, for 5 Days in Confinement and Prolonged by 86 Days in an Ambulatory Setting

Study identification

NCT ID: NCT01989156
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Philip Morris Products S.A.; Industry
Enrollment: 160 participants

Conditions and interventions

Conditions

Smoking

Interventions

THS 2.2 Menthol (mTHS 2.2) Other
Menthol Conventional Cigarette (mCC) Other
Smoking Abstinence (SA) Other

Other

Eligibility (public fields only)

Age range: 22 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2013
Primary completion: Sep 30, 2014
Completion: Apr 30, 2015
Last update posted: Mar 23, 2020

2013 – 2015

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Covance Daytona Beach, 1900 Mason Ave., Suite 140	Daytona Beach	Florida	32117	—
Covance Dallas, 1341 W. Mockingbird Ln., Ste 400E	Dallas	Texas	75247	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01989156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 23, 2020 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01989156 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →